Stem-cell transplantation for Crohn's disease: same authors, different conclusions?

Affiliations

¹ Division of Immunotherapy, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, USA. Electronic address: rburt@northwestern.edu.
² Kaiser Clinical Medical Center, São José do Rio Preto, São Paulo, Brazil.
³ Bone Transplantation Unit, Associação Portuguesa Beneficencia Hospital, São José Rio Preto, São Paulo, Brazil; Department of Genetics, State University of São Paulo, São José do Rio Preto, São Paulo, Brazil.

Comment

Richard K Burt et al. Lancet Gastroenterol Hepatol. 2017 Jun.

. 2017 Jun;2(6):386-387.

doi: 10.1016/S2468-1253(17)30076-6. Epub 2017 Apr 6.

¹ Division of Immunotherapy, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, USA. Electronic address: rburt@northwestern.edu.
² Kaiser Clinical Medical Center, São José do Rio Preto, São Paulo, Brazil.
³ Bone Transplantation Unit, Associação Portuguesa Beneficencia Hospital, São José Rio Preto, São Paulo, Brazil; Department of Genetics, State University of São Paulo, São José do Rio Preto, São Paulo, Brazil.

No abstract available

Comment on

Autologous stem-cell transplantation in treatment-refractory Crohn's disease: an analysis of pooled data from the ASTIC trial.
Lindsay JO, Allez M, Clark M, Labopin M, Ricart E, Rogler G, Rovira M, Satsangi J, Farge D, Hawkey CJ; ASTIC trial group; European Society for Blood and Marrow Transplantation Autoimmune Disease Working Party; European Crohn's and Colitis Organisation. Lindsay JO, et al. Lancet Gastroenterol Hepatol. 2017 Jun;2(6):399-406. doi: 10.1016/S2468-1253(17)30056-0. Epub 2017 Apr 6. Lancet Gastroenterol Hepatol. 2017. PMID: 28497755 Clinical Trial.